Literature DB >> 7883902

Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus.

J J Gray1, C Cunliffe, J Ball, D Y Graham, U Desselberger, M K Estes.   

Abstract

Pre- and postexposure sera collected from 17 adult volunteers challenged with Norwalk virus as described previously (D. Y. Graham, X. Jiang, T. Tanaka, A. Opekun, P. Madore, and M. K. Estes, J. Infect. Dis. 170:34-43, 1994) were examined for Norwalk virus-specific immunoglobulin M (IgM), IgA, and IgG by indirect enzyme-linked immunosorbent assays with recombinant Norwalk virus antigen bound to the solid phase. Sixteen of the 17 volunteers had evidence of past infection, all presenting with preexisting IgG antibody of high avidity; only one volunteer had no evidence of previous infection. Virus infection was detected in 14 of the 16 volunteers with evidence of past infection, and 9 of the infected volunteers had symptomatic illness. A significant rise in both virus-specific IgA and IgG titers was detected after challenge in all of the volunteers who became ill. Five of the asymptomatic volunteers who were infected had rising titers of virus-specific IgG, but only two of the five had a concomitant rise in their virus-specific IgA antibody titers. Antibody rises were detectable in eight of nine ill volunteers 8 to 11 days after challenge but in the asymptomatic volunteers only after more than 15 days had elapsed. Virus-specific IgM was detected after challenge in all 14 infected volunteers. Between symptomatic and asymptomatic volunteers there were no significant differences in titers of virus-specific IgG and IgA in serum before challenge; however, there were significantly higher titers in symptomatic volunteers between 8 and > 90 days after challenge for virus-specific IgG and 8 and 24 days after challenge for virus-specific IgA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7883902      PMCID: PMC264229          DOI: 10.1128/jcm.32.12.3059-3063.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Serum immunoglobulin A response to Norwalk virus infection.

Authors:  D D Erdman; G W Gary; L J Anderson
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

2.  Competition between, and effectiveness of, IgG and IgM antibodies in indirect fluorescent antibody and other tests.

Authors:  I R Cohen; L C Norins; A J Julian
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

3.  Norwalk virus infection of volunteers: new insights based on improved assays.

Authors:  D Y Graham; X Jiang; T Tanaka; A R Opekun; H P Madore; M K Estes
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

4.  Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed.

Authors:  S Inouye; A Hasegawa; S Matsuno; S Katow
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands.

Authors:  R W Ryder; N Singh; W C Reeves; A Z Kapikian; H B Greenberg; R B Sack
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

6.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

7.  Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay.

Authors:  N R Blacklow; G Cukor; M K Bedigian; P Echeverria; H B Greenberg; D S Schreiber; J S Trier
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

8.  Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis.

Authors:  H B Greenberg; J Valdesuso; R H Yolken; E Gangarosa; W Gary; R G Wyatt; T Konno; H Suzuki; R M Chanock; A Z Kapikian
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

9.  Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis.

Authors:  J E Kaplan; G W Gary; R C Baron; N Singh; L B Schonberger; R Feldman; H B Greenberg
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh.

Authors:  R E Black; H B Greenberg; A Z Kapikian; K H Brown; S Becker
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

View more
  25 in total

1.  Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis.

Authors:  Chris I Gallimore; David Cubitt; Nelita du Plessis; Jim J Gray
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.

Authors:  Samer S El-Kamary; Marcela F Pasetti; Paul M Mendelman; Sharon E Frey; David I Bernstein; John J Treanor; Jennifer Ferreira; Wilbur H Chen; Richard Sublett; Charles Richardson; Robert F Bargatze; Marcelo B Sztein; Carol O Tacket
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

3.  Serological correlate of protection against norovirus-induced gastroenteritis.

Authors:  Amanda Reeck; Owen Kavanagh; Mary K Estes; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

4.  Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses".

Authors:  G Belliot; J S Noel; J F Li; Y Seto; C D Humphrey; T Ando; R I Glass; S S Monroe
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Economic value of norovirus outbreak control measures in healthcare settings.

Authors:  B Y Lee; Z S Wettstein; S M McGlone; R R Bailey; C A Umscheid; K J Smith; R R Muder
Journal:  Clin Microbiol Infect       Date:  2010-10-26       Impact factor: 8.067

6.  Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection.

Authors:  J P Brinker; N R Blacklow; X Jiang; M K Estes; C L Moe; J E Herrmann
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 7.  Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses.

Authors:  R L Atmar; M K Estes
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Detection of Norwalk virus and other genogroup 1 human caliciviruses by a monoclonal antibody, recombinant-antigen-based immunoglobulin M capture enzyme immunoassay.

Authors:  J P Brinker; N R Blacklow; M K Estes; C L Moe; K J Schwab; J E Herrmann
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

9.  Economic impact of outbreaks of norovirus infection in hospitals.

Authors:  Bruce Y Lee; Sarah M McGlone; Rachel R Bailey; Zachary S Wettstein; Craig A Umscheid; Robert R Muder
Journal:  Infect Control Hosp Epidemiol       Date:  2011-02       Impact factor: 3.254

10.  Seroepidemiology of group C rotavirus infection in England and Wales.

Authors:  Miren Iturriza-Gómara; Ian Clarke; Ulrich Desselberger; David Brown; Daniel Thomas; Jim Gray
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.